TILT Holdings (TLLTF) Total Current Liabilities (2021 - 2025)
TILT Holdings (TLLTF) reported Total Current Liabilities of $124.1 million for Q2 2025, up 59.48% on a YoY basis from $77.8 million in Q2 2024, and little changed quarter-over-quarter from $124.4 million in Q1 2025.
TILT Holdings (TLLTF) Total Current Liabilities (2021 - 2025) Analysis & Trends
TILT Holdings has reported Total Current Liabilities for 5 years, with the latest figure at $124.1 million in Q2 2025.
- For the quarter ending Q2 2025, Total Current Liabilities rose 59.48% year-over-year to $124.1 million; the trailing twelve-month figure through Jun 2025 stood at $124.1 million (up 59.48% YoY), and the FY2024 full-year result was $87.5 million, up 14.99% from the prior year.
- Total Current Liabilities for Q2 2025 stood at $124.1 million, roughly flat from $124.4 million in the prior quarter.
- The five-year high for Total Current Liabilities was $136.7 million in Q2 2022, with the low at $63.1 million in Q2 2023.
- Historically, Total Current Liabilities has averaged $97.0 million across 5 years, with a median of $89.3 million in 2024.
- Annual changes were most pronounced in 2023 — Total Current Liabilities slumped 53.82% — and 2025, when it surged 59.48%.
- TILT Holdings' Total Current Liabilities stood at $99.5 million in 2021, then rose by 26.13% to $125.5 million in 2022, then plunged by 39.38% to $76.1 million in 2023, then grew by 14.99% to $87.5 million in 2024, then surged by 41.88% to $124.1 million in 2025.
- The last three Total Current Liabilities figures came in at $124.1 million (Q2 2025), $124.4 million (Q1 2025), and $87.5 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 333.17 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 618.78 Mn |
| 10 | TILT Holdings | - | - | 1.82 Mn | 124.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 124.11 Mn |
| Mar 31, 2025 | 124.39 Mn |
| Dec 31, 2024 | 87.47 Mn |
| Sep 30, 2024 | 83.44 Mn |
| Jun 30, 2024 | 77.83 Mn |
| Mar 31, 2024 | 91.06 Mn |
| Dec 31, 2023 | 76.07 Mn |
| Sep 30, 2023 | 74.88 Mn |
| Jun 30, 2023 | 63.13 Mn |
| Mar 31, 2023 | 63.57 Mn |
| Dec 31, 2022 | 125.50 Mn |
| Sep 30, 2022 | 129.67 Mn |
| Jun 30, 2022 | 136.70 Mn |
| Dec 31, 2021 | 99.50 Mn |